Nano-X Imaging Ltd.
NASDAQ:NNOX · NASDAQ Global Market
-$0.03 today
Vol 1.46M · Avg 1.46M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:NNOX · Revenue to Net Income
Key Ratios
Analysis
$13.0M of revenue converted into -$75.0M of net income for the selected period. Gross margin is -98.9% and net margin is -562.2%, showing how much revenue survives after costs and taxes. EPS is $-1.15, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.0M +15.4% | $11.3M +13.9% | $9.9M +15.5% | $8.6M +557.8% | $1.3M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $25.8M +17.9% | $21.9M +32.7% | $16.5M +6.7% | $15.5M +448.9% | $2.8M | $725.6M | $804.0M | $882.4M |
| Gross Profit | -$12.8M -20.5% | -$10.6M -60.9% | -$6.6M +4.2% | -$6.9M -355.0% | -$1.5M | $8.9B | $7.6B | $6.2B |
| Gross Margin | -98.2% -4.2pp | -94.0% -27.5pp | -66.6% +13.7pp | -80.2% +35.7pp | -116.0% | 9.8% | 28.9% | 38.3% |
| Research & Development | $19.2M -4.7% | $20.2M -22.5% | $26.0M -1.7% | $26.5M +54.8% | $17.1M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $27.1M +5.2% | $25.7M -9.3% | $28.4M -37.8% | $45.6M +9.3% | $41.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $47.9M +3.8% | $46.1M -17.6% | $56.0M -22.6% | $72.3M +20.5% | $60.0M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $11.7M -0.3% | $11.7M -0.7% | $11.8M +2.6% | $11.5M +402.3% | $2.3M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$49.0M -8.9% | -$45.0M +5.6% | -$47.7M +37.0% | -$75.7M -27.7% | -$59.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -376.3% +22.6pp | -398.9% +82.6pp | -481.5% +400.9pp | -882.4% +3662.5pp | -4544.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$60.7M -7.0% | -$56.7M +9.3% | -$62.6M +43.0% | -$109.7M -78.2% | -$61.6M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -466.2% +36.8pp | -502.9% +129.0pp | -631.9% +647.1pp | -1279.0% +3441.7pp | -4720.7% | 16.6% | 24.1% | 22.0% |
| Interest Income | $1.4M -50.4% | $2.9M +73.7% | $1.7M +109.4% | $789.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 -100.0% | $288.0K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$16.1M -661.0% | $2.9M +94.8% | $1.5M +110.0% | -$14.7M -4993.4% | -$288.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$76.8M -42.6% | -$53.9M +11.8% | -$61.1M +43.9% | -$108.9M -76.1% | -$61.8M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -589.9% -112.4pp | -477.5% +139.5pp | -617.0% +652.8pp | -1269.8% +3473.0pp | -4742.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$1.8M -400.6% | -$358.0K -5.6% | -$339.0K +90.8% | -$3.7M -7562.5% | -$48.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$75.0M -40.2% | -$53.5M +11.9% | -$60.8M +42.3% | -$105.2M -70.3% | -$61.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | -576.1% -101.8pp | -474.3% +139.3pp | -613.6% +613.3pp | -1226.9% +3512.2pp | -4739.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 -27.5% | -$1 +15.7% | -$1 +46.3% | -$2 -57.0% | -$1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 -27.5% | -$1 +15.7% | -$1 +46.3% | -$2 -57.0% | -$1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $64.8M +10.5% | $58.6M +4.0% | $56.4M +7.9% | $52.2M +8.3% | $48.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $64.8M +10.5% | $58.6M +4.0% | $56.4M +7.9% | $52.2M +8.3% | $48.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Perspective Therapeutics, Inc.
AMEX:CATX
$231.36M
Profound Medical Corp.
NASDAQ:PROF
$204.95M
Inogen, Inc.
NASDAQ:INGN
$173.95M
Quanterix Corporation
NASDAQ:QTRX
$155.92M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$149.37M
Health Catalyst, Inc.
NASDAQ:HCAT
$128.95M
MaxCyte, Inc.
NASDAQ:MXCT
$125.87M
Solana Company
NASDAQ:HSDT
$94.00M
Outset Medical, Inc.
NASDAQ:OM
$87.68M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$78.81M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does NNOX generate?
Nano-X Imaging Ltd. (NNOX) reported $13.02M of revenue in fiscal 2025.
Is NNOX profitable?
Nano-X Imaging Ltd. (NNOX) reported -$75,018,000.00 of net income, with a net margin of -576.1%.
Explore More
Continue the stock analysis
Jump to another research area for this company.